25 A similar case report details a 73-year-old male patient with T2DM, treated with metformin, as well as severe psoriasis, refractory to adalimumab, who was treated with semaglutide
Continued research led to the first GLP-1 drugs approved for weight loss in people with obesity or overweight: liraglutide or Saxenda in 2014, semaglutide as Wagovy in 2021 and tirzepatide as Zepbound in 2023
After injecting, gently press the site with a clean tissue or cotton pad for a few seconds
IMPORTANT MEDICAL DISCLAIMER Welloop is for tracking, organization, and educational purposes only
If you need nutritional support while adjusting to treatment, the GLP-1 Daily Support supplement is designed for that kind of day-to-day support alongside your plan
Contact your doctor if this happens during a randomized controlled trial